SNGX

SOLIGENIX, INC.

Pharmaceutical PreparationsNasdaqNon-accelerated filer<br>Smaller reporting company

Total Trades

2

Buys

2

Sells

0

Largest Trade

$1K–$15K

Insiders

2

Institutional Funds

15

Inst. Value

$100K–$500K

Activist Filings

3

Insider Trades

InsiderTitleTypeValueSharesPriceDate
Straube RichardSENIOR VICE PRESID…BUY$1K–$15K8K$0.50May 18, 2022
SCHABER CHRISTOPHER JCHAIRMANBUY$1K–$15K20K$0.44May 18, 2022
🔓Seeing ranges? Sign in for exact trade values — free forever

Institutional Ownership

13F filings as of Dec 31, 2025 · 15 funds holding

FundShares
DRW Securities, LLC125K
GEODE CAPITAL MANAGEMENT, LLC70K
VANGUARD GROUP INC54K
JANE STREET GROUP, LLC38K
StoneX Group Inc.38K
UBS Group AG23K
Virtu Financial LLC15K
MORGAN STANLEY4K
CITIGROUP INC577
Plante Moran Financial Advisors, LLC209
IFP Advisors, Inc50
SBI Securities Co., Ltd.2
ALBION FINANCIAL GROUP /UT1
Motiv8 Investments LLC3
CWM, LLC6

Activist & 5%+ Owners

SC 13D/13G filings — investors holding 5%+ of outstanding shares

Armistice Capital, LLC

SC 13G/A · Feb 18, 2026

5.0%

530K shares

Armistice Capital, LLC

SC 13G · Nov 14, 2025

6.7%

708K shares

Mitchell P. Kopin

SC 13G · Oct 1, 2025

5.0%

446K shares

View on Google Finance →